These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3020442)

  • 41. Renal effects of angiotensin converting enzyme inhibitors in hypertension.
    Bauer JH; Reams GP
    Am J Med; 1986 Oct; 81(4C):19-27. PubMed ID: 3022581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Some advances in angiotensin converting enzyme inhibitors].
    Jia L
    Sheng Li Ke Xue Jin Zhan; 1985 Jul; 16(3):229-34. PubMed ID: 3003897
    [No Abstract]   [Full Text] [Related]  

  • 43. Hypertension: calcium-blocking agents in treatment.
    Ambrose JE
    J Am Osteopath Assoc; 1984 Jan; 83(5):353-60. PubMed ID: 6321407
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis.
    Gemici K; Baran I; Bakar M; Demircan C; Ozdemir B; Cordan J
    Blood Press; 2003; 12(1):46-8. PubMed ID: 12699135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium channel blockers in systemic hypertension.
    Frishman WH; Charlap S; Michelson EL
    Am J Cardiol; 1986 Jul; 58(1):157-60. PubMed ID: 3524178
    [No Abstract]   [Full Text] [Related]  

  • 46. Quality of life in the treatment of hypertension. The effect of calcium antagonists.
    Fletcher A; Bulpitt C
    Drugs; 1992; 44 Suppl 1():135-40. PubMed ID: 1283577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Drug information. New principle in the treatment of elevated blood pressure].
    Dahlerup J
    Sygeplejersken; 1985 Jul; 85(27):16-7. PubMed ID: 3000014
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of circulatory diseases: recent progress. 1. Hypertension].
    Takeda T
    Nihon Naika Gakkai Zasshi; 1986 Jul; 75(7):848-55. PubMed ID: 3023507
    [No Abstract]   [Full Text] [Related]  

  • 49. Prolonged rat heart allograft survival after treatment with angiotensin converting enzyme inhibitor or a calcium antagonist.
    Mjörnstedt L; Lukes D; Arvidsson N; Herlitz H; Olausson M
    Scand J Urol Nephrol; 1998 Sep; 32(5):341-4. PubMed ID: 9825397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapy of severe hypertension].
    Greminger P
    Dtsch Med Wochenschr; 1987 Sep; 112(36):1383-4. PubMed ID: 3040369
    [No Abstract]   [Full Text] [Related]  

  • 51. Calcium antagonists in the treatment of hypertension.
    Heidland A; Heidbreder E; Hörl WH; Schäfer R
    Contrib Nephrol; 1982; 33():254-69. PubMed ID: 6749422
    [No Abstract]   [Full Text] [Related]  

  • 52. Angiotensin converting enzyme inhibition: a new therapeutic modality.
    Gavras H; Charocopos F; Brunner H; Gavras I
    Bull N Y Acad Med; 1981 May; 57(4):304-10. PubMed ID: 6164426
    [No Abstract]   [Full Text] [Related]  

  • 53. [Converting enzyme inhibitors in the treatment of essential hypertension].
    Sancho Rof J
    Med Clin (Barc); 1985 Nov; 85(14):578-80. PubMed ID: 3001445
    [No Abstract]   [Full Text] [Related]  

  • 54. Restoration of cardiac function and structure by converting enzyme inhibition possibilities and limitations of long-term treatment in hypertension and heart failure.
    Fouad FM; Tarazi RC
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S53-7. PubMed ID: 2422493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of human arterial hypertension. Role of calcium channel inhibitors].
    Thibonnier M
    Presse Med; 1985 Feb; 14(4):213-7. PubMed ID: 3156359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Inhibition of angiotensin converting enzyme as a therapeutic approach: the pros and cons].
    Waeber B; Waeber G; Nussberger J; Brunner HR
    Rev Med Brux; 1986 Apr; 7(4):227-30. PubMed ID: 3014629
    [No Abstract]   [Full Text] [Related]  

  • 57. Calcium antagonists in hypertension.
    Lancet; 1982 Aug; 2(8293):307-8. PubMed ID: 6124721
    [No Abstract]   [Full Text] [Related]  

  • 58. Converting-enzyme inhibition and glomerular filtration rate in essential hypertension.
    Bianchi MD; Fernandes M
    N Engl J Med; 1980 Jan; 302(3):179. PubMed ID: 6243169
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of calcium-entry antagonists in hypertension.
    Krebs R; Graefe KH; Ziegler R
    Clin Exp Hypertens A; 1982; 4(1-2):271-84. PubMed ID: 7074989
    [No Abstract]   [Full Text] [Related]  

  • 60. Calcium blockers: more than angina.
    Merz B
    JAMA; 1982 Sep; 248(11):1285-7. PubMed ID: 7050429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.